Navigation Links
ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
Date:7/6/2010

CHICAGO, July 6 /PRNewswire/ -- ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), has been engaged to sell a patent portfolio of near-infrared spectroscopy technology owned by NIResults Inc. The portfolio includes over 90 issued US and foreign patents and patent applications.  The assets have been cited by over 20 companies including Abbott Laboratories, Baxter International, Bayer Healthcare, Beckman Coulter Inc., Xerox, and Hewlett Packard.

(Logo: http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100614/CG20517LOGO)

The patents of this portfolio cover the use of near-infrared spectroscopy in clinical chemistry analysis systems, pulse oximeters and CO-oximeters, non-invasive glucose monitors, and hemoglobin monitors. The patents describe a method for the monitoring of key blood analytes without the need for costly, environmentally challenging, chemical reagents. The assets also include in-vitro, which is applied to a droplet of blood from a sample, and in-vivo (non-invasive) technology, which does not require a blood sample. Using near-infrared spectroscopy technology to count analytes in the blood eliminates the disadvantages associated with conventional methods such as the risk of patient infection and discomfort from invasive sampling methods and erroneous test results due to time delays between when the blood is drawn and analyzed.

"This portfolio will provide the purchaser with the coverage necessary to develop next generation monitoring devices," said Dean Becker, ICAP Ocean Tomo CEO. This portfolio should be of interest to any entity involved in diabetes management or blood monitoring markets, or developing products for analyte measurement.

To learn more about the patents available for sale in this portfolio or how to sell or buy intellectual property please contact ICAP Ocean Tomo at 1-866-779-8363 or at patent.brokerage@us.icap.com.

About ICAP Ocean Tomo LLC

ICAP Ocean Tomo is the intellectual property brokerage division of ICAP.

About ICAP

ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP is also the source of global market information and research for professionals in the international financial markets. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.


'/>"/>
SOURCE ICAP Ocean Tomo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
2. Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
3. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
4. HealthWarehouse.com Now Offers Over 1,000 Medications Under $25 Bringing Increased Affordability to Consumers
5. BSGI Offers Improved Cancer Detection for Negative or Indeterminate Mammograms
6. In the Face of Pain® Offers Social Media 101 for Pain Management Advocates
7. Medicalequipmentpro.com Offers Fathers Day Discounts to Ensure this Fathers Day is a Healthy One
8. Prolifiq Offers Best Practices Solution for Selling Medical Devices in Tough Regulatory Environment
9. Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)
10. Blog Contest Offers Graduate Students the Chance to Win a Trip to Zambia
11. BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... ... On Saturday, October 21, the Health & Wellness Center at Florida Hospital ... for the American Heart Association Heart Walk. Teams of up to 10 people can ... their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. on Saturday, ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):